Bereich
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
The p41 isoform of invariant chain is a chaperone for cathepsin L
Lennon-Dumenil A, Ploegh H, Bikoff E, Peters P, Erickson A, Overkleeft H, Driessen C, Valentijn K, Roberts R, Wolf Bryant P. The p41 isoform of invariant chain is a chaperone for cathepsin L. The EMBO journal 2001; 20:4055-64.
01.08.2001The p41 isoform of invariant chain is a chaperone for cathepsin L
01.08.2001The EMBO journal 2001; 20:4055-64
Lennon-Dumenil A M, Ploegh H L, Bikoff E, Peters P J, Erickson A, Overkleeft H S, Driessen Christoph, Valentijn K, Roberts R A, Wolf Bryant P
Anastrozole: pharmacological and clinical profile in postmenopausal women with breast cancer
Köberle D, Thürlimann B. Anastrozole: pharmacological and clinical profile in postmenopausal women with breast cancer. Expert review of anticancer therapy 2001; 1:169-76.
01.08.2001Anastrozole: pharmacological and clinical profile in postmenopausal women with breast cancer
01.08.2001Expert review of anticancer therapy 2001; 1:169-76
Köberle Dieter, Thürlimann Beat
[Neurogenic appendicopathy: a frequent, almost unknown disease picture. Evaluation of 816 appendices and review of the literature]
Gueller U, Oertli D, Terracciano L, Harder F. [Neurogenic appendicopathy: a frequent, almost unknown disease picture. Evaluation of 816 appendices and review of the literature]. Chirurg 2001; 72:684-9.
01.06.2001[Neurogenic appendicopathy: a frequent, almost unknown disease picture. Evaluation of 816 appendices and review of the literature]
01.06.2001Chirurg 2001; 72:684-9
Gueller Ulrich, Oertli D, Terracciano L, Harder F
Elevated carbohydrate antigen 19-9 (CA 19-9) in patients with Echinococcus infection
Pfister M, Gottstein B, Kretschmer R, Cerny T. Elevated carbohydrate antigen 19-9 (CA 19-9) in patients with Echinococcus infection. Clinical chemistry and laboratory medicine : CCLM / FESCC 2001; 39:527-30.
01.06.2001Elevated carbohydrate antigen 19-9 (CA 19-9) in patients with Echinococcus infection
01.06.2001Clinical chemistry and laboratory medicine : CCLM / FESCC 2001; 39:527-30
Pfister M, Gottstein B, Kretschmer R, Cerny Thomas
Individual cathepsins degrade immune complexes internalized by antigen-presenting cells via Fcgamma receptors
Driessen C, Lennon-Dumenil A, Ploegh H. Individual cathepsins degrade immune complexes internalized by antigen-presenting cells via Fcgamma receptors. European journal of immunology 2001; 31:1592-601.
01.05.2001Individual cathepsins degrade immune complexes internalized by antigen-presenting cells via Fcgamma receptors
01.05.2001European journal of immunology 2001; 31:1592-601
Driessen Christoph, Lennon-Dumenil A M, Ploegh H L
Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112-1115, 2001
Wagner U, Krebs D, Bauknecht T, Kreienberg R, Möbus V, Biersack H, Schlebusch H, Renke K, Huober J, Giffels P, Reinartz S, Köhler S, Wallwiener D. Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112-1115, 2001. Clinical cancer research : an official journal of the American Association for Cancer Research 2001; 7:1154-62.
01.05.2001Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112-1115, 2001
01.05.2001Clinical cancer research : an official journal of the American Association for Cancer Research 2001; 7:1154-62
Wagner U, Krebs D, Bauknecht T, Kreienberg R, Möbus V, Biersack H J, Schlebusch H, Renke K, Huober Jens, Giffels P, Reinartz S, Köhler S, Wallwiener D
Taxanes in lung cancer: a review with focus on the European experience
Calderoni A, Cerny T. Taxanes in lung cancer: a review with focus on the European experience. Critical reviews in oncology/hematology 2001; 38:105-27.
01.05.2001Taxanes in lung cancer: a review with focus on the European experience
01.05.2001Critical reviews in oncology/hematology 2001; 38:105-27
Calderoni A, Cerny Thomas
Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL
Li S, Gillessen Sommer S, Tomasson M, Dranoff G, Gilliland D, Van Etten R. Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL. Blood 2001; 97:1442-50.
01.03.2001Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL
01.03.2001Blood 2001; 97:1442-50
Li S, Gillessen Sommer Silke, Tomasson M H, Dranoff G, Gilliland D G, Van Etten R A
Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3
Tomasson M, Williams I, Li S, Kutok J, Cain D, Gillessen Sommer S, Dranoff G, Van Etten R, Gilliland D. Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3. Blood 2001; 97:1435-41.
01.03.2001Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3
01.03.2001Blood 2001; 97:1435-41
Tomasson M H, Williams I R, Li S, Kutok J, Cain D, Gillessen Sommer Silke, Dranoff G, Van Etten R A, Gilliland D G
High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel
Crivellari D, Goldhirsch A, Sessa C, Graffeo R, Martinelli G, Bauer J, Borner M, Hess D, Thürlimann B, Nolé F, Lombardi D, Veronesi A, Pagani O, International Breast Cancer Study Group. High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001; 12:353-6.
01.03.2001High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel
01.03.2001Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001; 12:353-6
Crivellari D, Goldhirsch A, Sessa C, Graffeo R, Martinelli G, Bauer J, Borner M, Hess Dagmar, Thürlimann Beat, Nolé F, Lombardi D, Veronesi A, Pagani O, International Breast Cancer Study Group
Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cells
Pichert G, Stahel R, Schmitter D, Stupp R, Betticher D, Cogliatti S, Cerny T, Hess U, Schmitz S, Ghielmini M. Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cells. Clinical lymphoma 2001; 1:293-7.
01.03.2001Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cells
01.03.2001Clinical lymphoma 2001; 1:293-7
Pichert G, Stahel R A, Schmitter D, Stupp R, Betticher D, Cogliatti S B, Cerny Thomas, Hess U, Schmitz S F, Ghielmini M
Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity
Gillessen Sommer S, Mach N, Small C, Mihm M, Dranoff G. Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity. Blood 2001; 97:922-8.
15.02.2001Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity
15.02.2001Blood 2001; 97:922-8
Gillessen Sommer Silke, Mach N, Small C, Mihm M, Dranoff G
Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation
Teshima T, Mach N, Hill G, Pan L, Gillessen Sommer S, Dranoff G, Ferrara J. Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation. Cancer research 2001; 61:162-71.
01.01.2001Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation
01.01.2001Cancer research 2001; 61:162-71
Teshima T, Mach N, Hill G R, Pan L, Gillessen Sommer Silke, Dranoff G, Ferrara J L
Impact of neurorehabilitation on disability in patients with acutely and chronically disabling diseases of the nervous system measured by the Extended Barthel Index
Jörger M, Beer S, Kesselring J. Impact of neurorehabilitation on disability in patients with acutely and chronically disabling diseases of the nervous system measured by the Extended Barthel Index. Neurorehabilitation and neural repair 2001; 15:15-22.
01.01.2001Impact of neurorehabilitation on disability in patients with acutely and chronically disabling diseases of the nervous system measured by the Extended Barthel Index
01.01.2001Neurorehabilitation and neural repair 2001; 15:15-22
Jörger Markus, Beer S, Kesselring J
Entzugssymptome der modernen Antidepressiva
Jörger M, Kuhn M, Hartmann K. Entzugssymptome der modernen Antidepressiva. Schweizerische Aerztezeitung 2001; 83
01.01.2001Entzugssymptome der modernen Antidepressiva
01.01.2001Schweizerische Aerztezeitung 2001; 83
Jörger Markus, Kuhn M, Hartmann K
Side Effects of Drugs Annual 24
Kuhn M, Jörger M, Hartmann K. Side Effects of Drugs Annual 24 - Drugs acting on the respiratory tract. In: Side Effects of Drugs Annual 24. Oxford UK: Elsevier; Linacre House Jordan Hill, 2001. ISBN 978-0-444-50512-5.
01.01.2001Side Effects of Drugs Annual 24
01.01.2001Elsevier; Linacre House Jordan Hill, ISBN 978-0-444-50512-5
Kuhn M, Jörger Markus, Hartmann K
Spiritualität - wesentliche Dimension gelingender Psychotherapie
Renz M, Riedel L. Spiritualität - wesentliche Dimension gelingender Psychotherapie. In: Couch oder Kirche. Riehen: Perspectiva, 2001. S. 285-304.
01.01.2001Spiritualität - wesentliche Dimension gelingender Psychotherapie
01.01.2001Perspectiva
Renz Monika, Riedel Lothar
Aus Urangst zum Urvertrauen
Renz M. Aus Urangst zum Urvertrauen. In: Was schätze ich am Christentum? 18 persönliche Antworten. Basel: Herder, 2001. S. 8-11.
01.01.2001Aus Urangst zum Urvertrauen
01.01.2001Herder
Renz Monika
Sterben? Letztes Tabu? Faszinierende Einsichten der neuen spirituell-therapeutischen Sterbebegleitung
Renz M. Sterben? Letztes Tabu? Faszinierende Einsichten der neuen spirituell-therapeutischen Sterbebegleitung. perspectiva 2001:20-21.
01.01.2001Sterben? Letztes Tabu? Faszinierende Einsichten der neuen spirituell-therapeutischen Sterbebegleitung
01.01.2001perspectiva 2001:20-21
Renz Monika
Leben lernen - Sterben lernen
Renz M. Leben lernen - Sterben lernen - Kommunikation am Sterbebett. Schweizer Krebsbulletin 2001; 21:193-195.
01.01.2001Leben lernen - Sterben lernen
01.01.2001Schweizer Krebsbulletin 2001; 21:193-195
Renz Monika